Olshan Closes Footstar Acquisition of CPEX Pharma

Olshan’s client Footstar, Inc., announced the acquisition of CPEX Pharmaceuticals, Inc. valued at approximately $76 million. The Olshan team that worked on this lengthy complex transaction included: Corporate: Kenneth A. Schlesinger, Jason W. Soncini and Camielle N. Green; Litigation: Thomas J. Fleming; and Tax: Nina Krauthamer.